We possess particular expertise in developing aptamers for a wide range of complex protein targets—such as membrane proteins, kinases, cytokines, and antibodies. By optimizing screening strategies, we overcome challenges that are difficult to resolve with traditional methods, delivering highly specific aptamers with performance comparable to or even surpassing that of monoclonal antibodies. For small molecules—including hormones, toxins, and antibiotics—we employ unique library construction and screening technologies. These effectively address the challenge of limited epitopes in small-molecule targets, providing clients with key recognition elements for applications in small-molecule detection, environmental monitoring, food safety, and beyond.
We offer one-stop peptide screening services, ranging from library design and high-throughput screening to functional validation. Leveraging our diverse peptide libraries (including random libraries, phage display libraries, cyclic peptide libraries, etc.), we can rapidly identify functional peptides with high affinity and specificity for specific targets. These peptide molecules hold broad application potential in areas such as drug lead compound development, cell-penetrating peptides, and core raw materials for diagnostic reagents.
Accelerate discovery with our AI-driven peptide screening. We rapidly identify high-potential candidates for therapeutics and diagnostics, maximizing hit rates while minimizing time and cost. Partner with us to streamline your path from target to lead. Unlock precise results.